MSME (Udyam registered) Ministry of MSME
- Category
- Micro (2021-22)
- Udyam number
- UDYAM-MH-19-0087870
Mednosis Pharmaceuticals Private Limited
Mednosis Pharmaceuticals Private Limited - healthcare in Mumbai, Maharashtra, India. Directors, charges & compliance details.
Revenue · FY 2025
₹48.89 Lakh
▲ 77% YoY
Net profit · FY 2025
₹49,757
Net margin 1%
EBITDA · FY 2025
₹94,855
EBITDA margin 1.9%
Authorised capital
₹1 Lakh
Registered with MCA
Paid-up capital
₹1 Lakh
Issued & subscribed
Company age
5 yrs
Est. 2021
Directors on board
2
As per MCA filings
Last financials
Mar 2025
Balance sheet date
About Mednosis Pharmaceuticals Private Limited
Data last updated:
Mednosis Pharmaceuticals Private Limited is a private limited company based in Mumbai, Maharashtra, India. It operates in the medical appliances and instruments segment of the healthcare sector. It was incorporated on 22 June 2021 and has been in existence for over 5 years.
The company is registered with the Registrar of Companies (ROC), Mumbai, under CIN U33100MH2021PTC362510.
The company has an authorised share capital of ₹1 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors Mohammad Muneer and Parveen Mohammad Muneer.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Mumbai, Maharashtra.
As per the financials filed for FY 2025, the company reported a revenue of ₹48.89 Lakh, a growth of 77% compared to the previous year. For the same year it recorded a net profit of ₹49,757 (net margin 1%) and EBITDA of ₹94,855 (EBITDA margin 1.9%). Revenue has grown at a compounded annual rate (CAGR) of 401% over three years.
Mednosis Pharmaceuticals Private Limited is registered as a micro enterprise under the Udyam registration framework (Reg. No. UDYAM-MH-19-0087870). The current compliance status is marked as compliant by the Registrar of Companies.
Company details
CIN U33100MH2021PTC362510
Registration Number 362510
Incorporation Date 22 June 2021
ROC Mumbai
Listing Status Unlisted
Company Status Active
Date of Last AGM 30 September 2025
Date of Balance Sheet 31 March 2025
Compliance Status Active Compliant
MSME Classification Micro
Udyam Registration UDYAM-MH-19-0087870
Recognitions & Rankings of Mednosis Pharmaceuticals
Contact details
Mednosis Pharmaceuticals Private Limited's registered office is in Mumbai, Maharashtra.
- Registered AddressShop No. D – 11 Ground Floor Premier Exotica – 1 D Wing, Kirol Road Kurla West, Mumbai, Maharashtra, India – 400070
- IndustryHealthcare, Medical Appliances And Instruments, Manufacturing
Comprehensive company report
Mednosis Pharmaceuticals Private Limited - one report that includes everything
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included
Business activity
The main business activity of Mednosis Pharmaceuticals is wholesale and retail trade; repair of motor vehicles and motorcycles. In detail, this covers wholesale trade, except of motor vehicles and motorcycles.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| G | Wholesale and retail trade; repair of motor vehicles and motorcycles | 46 | Wholesale trade, except of motor vehicles and motorcycles |
To see the full business activity and turnover split of Mednosis Pharmaceuticals Private Limited, buy the company report.
Financials of Mednosis Pharmaceuticals Private Limited
FY 2025 filings availableMednosis Pharmaceuticals Private Limited reported revenue of ₹48.89 Lakh (up 77% YoY) for FY 2025.
Revenue · FY 2025
₹48.89 Lakh ▲ 77%
Net profit · FY 2025
₹49,757 margin 1%
EBITDA · FY 2025
₹94,855 margin 1.9%
Compounded Annual Growth Rate (CAGR)
Revenue CAGR growth
1 year
▲ 77%
3 years · compounded
▲ 401%
EBITDA CAGR growth
1 year
▲ 88%
3 years · compounded
▲ 35%
Revenue has grown at a compounded annual rate (CAGR) of 401% over three years, including 77% growth in the latest year. EBITDA rose 88% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 |
|---|---|---|---|---|
| Profit and Loss Statement | ||||
| Revenue from Operations | ||||
| Other Income | ||||
| Total Revenue | ||||
| Cost of Materials Consumed | ||||
| Employee Benefit Expense | ||||
| Finance Costs | ||||
| Depreciation and Amortisation | ||||
| Other Expenses | ||||
| Total Expenses | ||||
| EBITDA | ₹94,855 | |||
| Profit Before Tax | ||||
| Tax Expense | ||||
| Net Profit (PAT) | ₹49,757 | |||
| Balance Sheet | ||||
| Share Capital | ||||
| Reserves and Surplus | ||||
| Net Worth (Total Equity) | ||||
| Long-term Borrowings | ||||
| Short-term Borrowings | ||||
| Trade Payables | ||||
| Total Liabilities | ||||
| Fixed Assets | ||||
| Investments | ||||
| Inventories | ||||
| Trade Receivables | ||||
| Cash and Bank Balance | ||||
| Total Assets | ||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 |
|---|---|---|---|---|
| Profitability | ||||
| EBITDA Margin | 1.9% | |||
| Net Profit Margin | 1% | |||
| Return on Equity (ROE) | ||||
| Return on Capital Employed (ROCE) | ||||
| Return on Assets (ROA) | ||||
| Liquidity and Debt | ||||
| Current Ratio | ||||
| Quick Ratio | ||||
| Debt-to-Equity Ratio | ||||
| Interest Coverage Ratio | ||||
| Efficiency and Growth | ||||
| Asset Turnover | ||||
| Receivable Days | ||||
| Payable Days | ||||
| Inventory Days | ||||
| Revenue Growth | ||||
| Net Profit Growth | ||||
To see the full financial statements and ratios of Mednosis Pharmaceuticals Private Limited, buy the company report.
Board of directors of Mednosis Pharmaceuticals Private Limited
Mednosis Pharmaceuticals has 2 current directors and 2 former directors. Current directors are listed first, with their designation and appointment date.
Current Directors
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Mohammad Muneer | Director | 22 Jun 2021 | 5 Years 4 Months | Current |
| Parveen Mohammad Muneer | Director | 03 Dec 2024 | 1 Years 11 Months | Current |
Legal cases
No court or tribunal cases involving Mednosis Pharmaceuticals Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Mednosis Pharmaceuticals Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
No GST registration is on our record for Mednosis Pharmaceuticals Private Limited; the GSTIN and return-filing check is in the company report Buy the company report.
Recent activity
Mednosis Pharmaceuticals Private Limited has 4 board changes on record since 2021: 3 appointments and 1 cessation. The latest: Parveen Mohammad Muneer was appointed as Director on 03 Dec 2024.
AGM
Mednosis Pharmaceuticals Private Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records.
Filing
Mednosis Pharmaceuticals Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Mumbai I.
Appointed
Parveen Mohammad Muneer was appointed as Director.
Ceased
Manoj Kumar Mali ceased to be Director.
Appointed
Rahimunisha Mohammed Rasheed Chaudhary was appointed as Director.
Appointed
Mohammad Muneer was appointed as Director.
Incorporation
22 Jun 2021
Mednosis Pharmaceuticals Private Limited was registered on 22 Jun 2021 with Roc Mumbai I & aged 5 years 4 months as per MCA records.
Frequently asked questions
Mednosis Pharmaceuticals is an active private limited company based in Mumbai, Maharashtra, India. The company works in medical appliances and instruments, within the healthcare industry. It was incorporated on 22 June 2021 (5+ years old) and is registered under CIN U33100MH2021PTC362510.
Mednosis Pharmaceuticals has 2 current directors:
- Mohammad Muneer - Director
- Parveen Mohammad Muneer - Director
The latest financial statements of Mednosis Pharmaceuticals on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from FY 2022 are in the company report.
The CIN (Corporate Identification Number) of Mednosis Pharmaceuticals is U33100MH2021PTC362510. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Mednosis Pharmaceuticals was incorporated on 22 June 2021, making it 5+ years old. It is registered with the Registrar of Companies, Mumbai.
Parveen Mohammad Muneer was appointed as Director on 03 Dec 2024. Manoj Kumar Mali ceased to be Director on 13 Aug 2021. Rahimunisha Mohammed Rasheed Chaudhary was appointed as Director on 13 Aug 2021. Mednosis Pharmaceuticals has 4 board changes on record in total.
Yes, Mednosis Pharmaceuticals is registered as a micro enterprise under Udyam registration (number: UDYAM-MH-19-0087870).
The registered office of Mednosis Pharmaceuticals is at Shop No. D – 11 Ground Floor Premier Exotica – 1 D Wing, Kirol Road Kurla West, Mumbai, Maharashtra, India – 400070.
Mednosis Pharmaceuticals operates in the healthcare industry, in the medical appliances and instruments segment.
The compliance status of Mednosis Pharmaceuticals is compliant as of 28 September 2026. The company is actively filing with the Registrar of Companies.
Sample company reports
The same report you get when you buy one: financials, directors, ownership, deals, charges, legal cases, brands and filings, with the Excel workbook alongside.
Swiggy Limited Listed company · 92 pages
BharatPe (Resilient Innovations Pvt Ltd) Unlisted company · 78 pages